Portland, OR, Nov. 06, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Alzheimer’s therapeutics market was estimated at $6.1 billion in 2021 and is expected to hit $13 billion by 2031, registering a CAGR of 8.1% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/10900
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $6.1 Billion |
| Market Size in 2031 | $13 Billion |
| CAGR | 8.1% |
| No. of Pages in Report | 310 |
| Segments Covered | Drug Class, Distribution Channel, and Region. |
| Drivers | Increase in the prevalence of Alzheimer’s disease across both the developed and developing countries |
| Opportunities | Advancements in treatment, and drug discovery techniques, |
Covid-19 scenario-
- Patients who suffered from Alzheimer’s disease were more vulnerable to be infected by coronavirus.
- Rise in number of Covid-19 infection in patients with Alzheimer’s disease led to increase in demand for Alzheimer’s therapeutics during the pandemic period.
The global Alzheimer’s therapeutics market is analyzed across drug class, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on drug class, the cholinesterase inhibitors segment garnered more than half of the total market revenue in 2021, and is expected to dominate by 2031. The others segment, simultaneously, would manifest the fastest CAGR of 22.0% throughout the forecast period. The N-Methyl-D-Aspartate (NMDA) receptor antagonist segment is also assessed in the report.
By distribution channel, the drug store and retail pharmacy segment held nearly three-fifths of the global Alzheimer’s therapeutics market in 2021, and is anticipated to retain its dominance by 2031. The online pharmacy segment, on the other hand, would cite the fastest CAGR of 11.9% during the forecast period. The hospital pharmacy segment is also analyzed through the report.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/10900
Based on region, the market across North America generated more than two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would manifest the fastest CAGR of 10.5% during the forecast period. The other regions studied in the report include LAMEA and Europe.
The key market players analyzed in the global Alzheimer’s therapeutics market report include AbbVie Inc., Biogen Inc., Merck & Co. Inc., Novartis AG, Eisai Co. Ltd., H.Lundbeck A/S, Daiichi Sankyo Company Ltd., Teva Pharmaceuticals Industries Ltd., Eli Lilly and Company, and Lupin. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Similar Research Reports for Information, Communication, and Technology:
Internet of Things in Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Medical Tourism Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
